A single shot of the H1N1 influenza vaccine can induce a strong immune response predictive of protection in asthma patients, a US study reveals.
Results from the US National Institute of Allergy and Infectious Diseases (NIAID) research found a 15mg dose of the vaccine was sufficient to provide protection against the pandemic flu virus in most patients.
NIAID director Dr Anthony Fauci said the findings of the trial were important, as asthma was the most common underlying condition leading to hospitalisation during the pandemic.
“The results of this clinical trial show that the 2009 H1N1 influenza vaccine was safe and led to adequate production of antibodies thought to be protective against this virus.
“This is important, because the H1N1 vaccine is one component of...
This site is intended for Registered Medical Practitioners.
To make the most of Pharmacy News, you need to be logged in.